A majority of cancers showed higher expression of lncRNA BCAR4 in tumor tissues when compared with normal tissues, including sarcoma (SARC), breast invasive carcinoma (BRCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PRAD), and stomach adenocarcinoma (STAD). Here, BCAR4 is linked to prostate adenocarcinoma.